The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Martin Dayton, DO - LDN Case Studies (2016 Conference) (LDN, low dose naltrexone)
Dr Martin Dayton shares three case studies of patients suffering from follicular B-cell non Hodgkin's Lymphoma who were treated with nothing more than Low Dose Naltrexone (LDN).
Nasha Winters, ND - Marrying Mistletoe with LDN (2018 Conference) (LDN, low dose naltrexone)
Russell - 29th May 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: Today, my guest is Russell from the United States who takes LDN for hypothyroidism, Graves' disease, a non-Hodgkin's lymphoma.
Thank you for joining us today, Russell.
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.